Trio Petroleum Corp 8-K Filing

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share TPET The NYSE American
• $3,600,000 — ng an aggregate offering price of up to $3,600,000, in connection with the Offering (the "
• $3,292,000 — shares that were available for sale was $3,292,000. The maximum aggregate offering amount
• $6,892,000 — e maximum aggregate offering amount was $6,892,000, which included shares of Common Stock
• $3,599,885 — tock having an aggregate sales price of $3,599,885 (7,344,372 shares of Common Stock) that
• $6,485,000 — shares that were available for sale was $6,485,000. The maximum aggregate offering amount
• $13,377,000 — e maximum aggregate offering amount was $13,377,000, which included shares of Common Stock
• $6,891,859 — tock having an aggregate sales price of $6,891,859 (9,254,648 shares of Common Stock) that
• $4,000,000 — shares that were available for sale was $4,000,000. The maximum aggregate offering amount
• $17,377,000 — e maximum aggregate offering amount was $17,377,000, which included shares of Common Stock
• $13,376,774 — tock having an aggregate sales price of $13,376,774 (15,348,345 shares of Common Stock) tha
• $1,641,000 — shares that were available for sale was $1,641,000 (the "Placement Shares"). The maximum a
• $19,018,000 — e maximum aggregate offering amount was $19,018,000, which included shares of Common Stock
• $17,375,884 — tock having an aggregate sales price of $17,375,884 (18,139,045 shares of Common Stock) tha
• $1,010,000 — shares that were available for sale was $1,010,000 (the "Placement Shares"). The maximum a

Filing Documents

• form8-k.htm (8-K) — 47KB
• ex5-1.htm (EX-5.1) — 12KB
• ex5-1_001.jpg (GRAPHIC) — 3KB
• 0001493152-26-015241.txt ( ) — 231KB
• tpet-20260406.xsd (EX-101.SCH) — 3KB
• tpet-20260406_lab.xml (EX-101.LAB) — 33KB
• tpet-20260406_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2026 Trio Petroleum Corp (Exact name of registrant as specified in its charter) Delaware 001-41643 87-1968201 (State or other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 23823 Malibu Road , Suite 304 Malibu , CA 90265 ( 661 ) 324-3911 (Address and telephone number, including area code, of registrant's principal executive offices) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:. Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share TPET The NYSE American Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 8.01. Other Events. On January 9, 2026, Trio Petroleum Corp, a Delaware corporation (the "Company"), filed a Current Report on Form 8-K (the "January 9 th 8-K") with the Securities and Exchange Commission (the "Commission") reporting that it had entered into an At Market Issuance Sales Agreement (the "ATM Agreement") with Ladenburg Thalmann & Co. Inc. as agent (the "Sales Agent") pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share ("Common Stock"), from time to time through the Sales Agent (the "Offering"). On January 9, 2026, the Company also filed a prospectus supplement with the Commission covering the sale of shares of Common Stock having an aggregate offering price of up to $3,600,000, in connection with the Offering (the "Prospectus Supplement"), along with the base prospectus (the "Base Prospectus"), under its existing Registration Statement on Form S-3 (File No 333-281813), which became effective on September 10, 2024 (the "Registration On March 3, 2026, the Company filed Amendment No. 1 to the Prospectus Supplement ("Amendment No. 1") amending and supplementing the Prospectus Supplement to update the amount of shares eligible for sale under General Instruction I.B.6 of Form S-3 ("Instruction I.B.6.). Following the filing of Amendment No. 1, the aggregate amount of shares that were available for sale was $3,292,000. The maximum aggregate offering amount was $6,892,000, which included shares of Common Stock having an aggregate sales price of $3,599,885 (7,344,372 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement. On March 4, 2026, the Company filed Amendment No. 2 to the Prospectus Supplement ("Amendment No. 2") further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 2, the aggregate amount of shares that were available for sale was $6,485,000. The maximum aggregate offering amount was $13,377,000, which included shares of Common Stock having an aggregate sales price of $6,891,859 (9,254,648 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended. On March 5, 2026, the Company filed Amendment No. 3 to the Prospectus Supplement ("Amendment No. 3") further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 3, the aggregate amount of shares that were available for sale was $4,000,000. The maximum aggregate offering amount was $17,377,000, which included shares of Common Stock having an aggregate sales price of $13,376,774 (15,348,345 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended. On March 10, 2026, the Company filed Amendment No. 4 to the Prospectus Supplement ("Amendment No. 4") further amending and supplementing th

View Full Filing

View this 8-K filing on SEC EDGAR